Search

This study uses the meta-cognitive model (developed in clinical psychology primarily in relation to depressive conditions) to explain the causal dynamics of why artists, in always looking for “perfection”, can experience mental states which predicate modes of overthinking which can be detrimental to their careers and/or projects. The meta-cognitive model proposes a specific causal relationship between metacognition and the regulation of thought processes, in which overthinking pertains to excessive metacognitive intervention or total lack thereof. The aim of this study is to establish a practical and implementable meta-cognitive intervention for arts practitioners, arts students, and teachers of arts practice, which will help in avoiding (or teaching how to avoid) the pitfalls of overthinking; to determine a practical “cognitive tool”, or mental framework, in the process of making arts. This meta-cognitive tool is intended as an abstract and intellectual complement to the concrete and formal compositional skills of art production. A key focus of this study concerns the liminal points between healthy/productive and unhealthy (and potentially pathological) aspects of creative overthinking, considering how excessive rumination factors into creative traits such as perfectionism and attention to detail in the production of artworks; looking, further, at how overthinking can affect the mind negatively, such as inducing anger and anxiety for example.

Background The incidence of septic arthritis is 2–10/100,000. Morbidity is higher with persistent joint dysfunction in up to 30%. Osteoarthritic knee with infection presents a rare challenge, with no established approach for treatment exists. We present our experience of managing infected degenerative joint disease (DJD) with two-stage primary arthroplasty similar to the management of periprosthetic joint infection. Patients and methods Four patients presented to us between 2016 and 2018 with advanced DJD associated with coexistent joint sepsis with or without adjacent osteomyelitis. The diagnosis of joint sepsis with periarticular osteomyelitis was made based on clinical presentation, radiographic findings, inflammatory serological markers, and culture of knee joint aspirate. All were operated with primary arthroplasty in two stages of debridement with a static spacer followed by antibiotics and implantation. Discussion With no established method of treating DJD superadded with infection, our experience adds valuable information in treating the same. Our 2-staged primary arthroplasty had a short antibiotic duration between stages, a mean of 63.5 days, and stopped within 3 days of 2ndstage reducing hospital stay, morbidity, and cost. Our approach is a very viable method of treating infected DJD with a minimum drug holiday time of two weeks before implantation with a better outcome, reducing the recurrence rate of infection. Though a small number with a minimum follow-up of 24 months, we believe we provide valuable additional information. Conclusion All patients had painless return to early activities with no signs of recurrent infection. Our approach is a very viable and could serve as a cost-effective method treatment for an infected arthritic knee.

Moringa oleifera (MO) has started to focus the attention of many researchers, especially in the last decade, due to its rich nutrient content and bioactive compounds that have numerous pharmaceutical potentials. In this systematic review, 36 research articles were included that explored the anti-obesity potential of MO through in-vitro and in-vivo studies. The research articles included 9 in-vitro studies, 27 in-vivo studies, and 3 clinical studies. The studies mainly focused on the extract of MO prepared using MO leaves and few studies particularly focused on MO isothiocyanates. The in-vitro studies were mainly based on 3T3-L1 cells, while the in-vivo studies involved a good range of male and female mice and rats. Only two research involved human studies. The major anti-obesity mechanisms of MO were through improving the lipid profile (levels of total cholesterol, triglycerides, low-density lipoprotein, very low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein cholesterol) and body weight, regulating significant genes associated with adipogenesis, glucose uptake, insulin resistance, and hormones (such as leptin, vaspin, resistin, and insulin). The clinical trials studying the anti-obesity potential of MO on humans is limited and related to the impact of MO on body mass index, total cholesterol, low-density lipoprotein, and postprandial blood glucose only.

The study reports formulation, characterization and in-vitro digestion of novel camel milk-based infant formula (IF) in comparison to bovine and commercial IF. Camel milk IF was further fortified with camel casein or whey at different levels to study the effect of different protein supplementation. A simulated infant gastrointestinal digestion (SIGID) model was used to compare the digestibility of different IFs. Protein digestibility of various IFs were studied through degree of hydrolysis (DH), sodium dodecyl sulphate-polyacrylamide gel electrophoresis, and reverse-phase ultra-performance liquid chromatography (RP-UPLC). Upon SIGID, camel milk IF fortified with 10% whey showed the highest DH (3092.2 μg NH3 g−1) followed by camel milk IF (1308.16 μg NH3 g−1) displaying generation of diverse peptides. The fate of proteins and fats after SIGID was also studied using fluorescence microscopy that reflected homogenous breakdown of the proteins and lipid fractions. Furthermore, the effect of SIGID on bioactive properties was also analyzed via antioxidant (ABTS and DPPH radical scavenging activities) and anti-inflammatory activities. After SIGID, camel IF samples fortified with whey and casein proteins showed superior radical scavenging and anti-inflammatory activities. The study concludes that camel milk can be a potential alternative for the development of infant formula with additional health benefits.

Human immunodeficiency virus type 1 (HIV-1) eradication is prevented by the establishment on infection of cellular HIV-1 reservoirs that are not fully characterized, especially in genital mucosal tissues (the main HIV-1 entry portal on sexual transmission). Here, we show, using penile tissues from HIV-1-infected individuals under suppressive combination antiretroviral therapy, that urethral macrophages contain integrated HIV-1 DNA, RNA, proteins and intact virions in virus-containing compartment-like structures, whereas viral components remain undetectable in urethral T cells. Moreover, urethral cells specifically release replication-competent infectious HIV-1 following reactivation with the macrophage activator lipopolysaccharide, while the T-cell activator phytohaemagglutinin is ineffective. HIV-1 urethral reservoirs localize preferentially in a subset of polarized macrophages that highly expresses the interleukin-1 receptor, CD206 and interleukin-4 receptor, but not CD163. To our knowledge, these results are the first evidence that human urethral tissue macrophages constitute a principal HIV-1 reservoir. Such findings are determinant for therapeutic strategies aimed at HIV-1 eradication. Suppressive combination antiretroviral therapy fails to eradicate HIV-1 latent reservoirs in poorly characterized cell compartments. Here, urethral macrophages, but not urethral T cells, are shown to contain integrated HIV-1 DNA and to be able to release infectious HIV-1 following reactivation with lipopolysaccharide.